Olema Pharmaceuticals, Inc. SC 13G and SC 13G/A reports

Location
780 Brannan Street, San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
11/12/2024, 04:17 PM
Form type Sec Links Description Filing date Reporting date
SC 13G Report OLEMA PHARMACEUTICALS INC. Jun 14, 2024
SC 13G Report Mar 22, 2024
SC 13G/A Report SC 13G/A Feb 14, 2024
SC 13G/A Report Feb 14, 2024
SC 13G/A Report KYNAM CAPITAL MANAGEMENT, LP Feb 14, 2024
SC 13G/A Report JHG PLC OWNS <5% Feb 12, 2024
SC 13G Report Jan 29, 2024
SC 13G/A Report SC 13G/A Sep 13, 2023
SC 13G Report SC 13G Apr 10, 2023
SC 13G/A Report KYNAM CAPITAL MANAGEMENT, LP Mar 22, 2023
SC 13G/A Report SC 13G/A Feb 14, 2023
SC 13G/A Report Feb 14, 2023
SC 13G Report KYNAM CAPITAL MANAGEMENT, LP Feb 10, 2023
SC 13G/A Report JHG PLC OWNS >5% Feb 10, 2023
SC 13G/A Report SCHEDULE 13G/A Feb 9, 2023
SC 13G/A Report SEC SCHEDULE 13G Feb 6, 2023
SC 13G/A Report SC 13G/A Nov 14, 2022
SC 13G Report Jul 8, 2022
SC 13G/A Report SC 13G/A May 16, 2022
SC 13G/A Report SC 13G/A Feb 14, 2022
SC 13G/A Report Feb 14, 2022
SC 13G Report SC 13G Feb 11, 2022
SC 13G/A Report JANUS HENDERSON GROUP PLC OWNS >5% Feb 10, 2022
SC 13G Report SCHEDULE 13G Feb 10, 2022
SC 13G Report Feb 4, 2022
SC 13G/A Report SEC SCHEDULE 13G Feb 4, 2022
SC 13G Report SCHEDULE 13G Feb 16, 2021
SC 13G/A Report Feb 16, 2021
SC 13G Report JANUS HENDERSON GROUP PLC OWNS >5% Feb 12, 2021
SC 13G Report SEC SCHEDULE 13G Feb 4, 2021
SC 13G Report Nov 23, 2020